Since this can not be a randomized, placeboed trial which is the gold standard
It can't even be a blinded trial, it seems to me, since if a patient gets a hole bored in his skull, he'll be getting Cotara. It is a dilemma for the FDA, I would imagine whether they'll be able to approve a drug based on an open-label trial.